BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

The Native Antigen Company Ltd Release: New - Highly Purified, Cost-Effective CMV Native Antigen for IgM


1/3/2012 9:04:29 AM

January 2012. The Native Antigen Company (NAC),http://thenativeantigencompany.com announces the release of a highly purified Cytomegalovirus (CMV) native antigen.

The antigen has been manufactured in response to the in-vitro diagnostics (IVD) industry’s requirement for a cost effective antigen which can demonstrate a high affinity for not only IgG but more importantly, for IgM. This latest antigen from NAC’s rapidly increasing portfolio also minimizes cross-reactivity and lot to lot variation. The company is well equipped to meet an anticipated high volume requirement from IVD manufacturers who major in this field.

Presently, CMV infection is mostly controlled in immune compromised patients by available antiviral drugs, yet it continues to maintain its role as one of the most dangerous infectious agents for the unborn infant. Primary infection is consistently associated with the presence of a virus specific IgM antibody response. Use of NAC’s CMV purified native antigen will aid in improving serology based assays for early detection.

For more information please contact The Native Antigen Company on +44 (0)1869 238067, contact@thenativeantigencompany.com

or visit www.thenativeantigencompany.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES